Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Karen Wernli and Sara Tartof.
Connection Strength

0.387
  1. Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network. medRxiv. 2023 Jan 11.
    View in: PubMed
    Score: 0.224
  2. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clin Infect Dis. 2022 Dec 12.
    View in: PubMed
    Score: 0.056
  3. Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza Other Respir Viruses. 2022 Nov; 16(6):975-985.
    View in: PubMed
    Score: 0.054
  4. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):365-370.
    View in: PubMed
    Score: 0.053

© 2024 Kaiser Permanente